Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors

被引：17

作者：

Miles, Dillon H. ^{[1
]}

Yan, Xuelei ^{[1
]}

Thomas-Tran, Rhiannon ^{[1
]}

Fournier, Jeremy ^{[1
]}

Sharif, Ehesan U. ^{[1
]}

Drew, Samuel L. ^{[1
]}

Mata, Guillaume ^{[1
]}

Lawson, Kenneth, V ^{[1
]}

Ginn, Elaine ^{[1
]}

Wong, Kent ^{[1
]}

Soni, Divyank ^{[1
]}

Dhanota, Puja ^{[1
]}

Shaqfeh, Stefan G. ^{[1
]}

Meleza, Cesar ^{[1
]}

Chen, Ada ^{[1
]}

Pham, Amber T. ^{[1
]}

Park, Timothy ^{[1
]}

Swinarski, Debbie ^{[1
]}

Banuelos, Jesus ^{[1
]}

Schindler, Ulrike ^{[1
]}

Walters, Matthew J. ^{[1
]}

Walker, Nigel P. ^{[1
]}

Zhao, Xiaoning ^{[1
]}

Young, Stephen W. ^{[1
]}

Chen, Jie ^{[1
]}

Jin, Lixia ^{[1
]}

Leleti, Manmohan Reddy ^{[1
]}

Powers, Jay P. ^{[1
]}

Jeffrey, Jenna L. ^{[1
]}

机构：

[1] Arcus Biosci Inc, Hayward, CA 94545 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 11期

关键词：

PI3K gamma; inhibitor; selective; azaindole; immunomodulation; cancer;

D O I：

10.1021/acsmedchemlett.0c00387

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The successful application of immunotherapy in the treatment of cancer relies on effective engagement of immune cells in the tumor microenvironment. Phosphoinositide 3-kinase gamma (PI3K gamma) is highly expressed in tumor-associated macrophages, and its expression levels are associated with tumor immunosuppression and growth. Selective inhibition of PI3K gamma offers a promising strategy in immunooncology, which has led to the development of numerous potent PI3K gamma inhibitors with variable selectivity profiles. To facilitate further investigation of the therapeutic potential of PI3K gamma inhibition, we required a potent and PI3K gamma-selective tool compound with sufficient metabolic stability for use in future in vivo studies. Herein, we describe some of our efforts to realize this goal through the systematic study of SARs within a series of 7-azaindole-based PI3K gamma inhibitors. The large volume of data generated from this study helped guide our subsequent lead optimization efforts and will inform further development of PI3K gamma-selective inhibitors for use in immunomodulation.

引用

页码：2244 / 2252

页数：9

共 50 条

[1] Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity
Yang, Chengbin
Zhang, Xi
Wang, Yi
Yang, Yongtai
Liu, Xiaofeng
Deng, Mingli
Jia, Yu
Ling, Yun
Meng, Ling-hua
Zhou, Yaming
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (08): : 875 - 880
[2] Discovery of Potent and Selective PI3Kγ Inhibitors
Drew, Samuel L.
Thomas-Tran, Rhiannon
Beatty, Joel W.
Fournier, Jeremy
Lawson, Kenneth, V
Miles, Dillon H.
Mata, Guillaume
Sharif, Ehesan U.
Yan, Xuelei
Mailyan, Artur K.
Ginn, Elaine
Chen, Jie
Wong, Kent
Soni, Divyank
Dhanota, Puja
Chen, Pei-Yu
Shaqfeh, Stefan G.
Meleza, Cesar
Pham, Amber T.
Chen, Ada
Zhao, Xiaoning
Banuelos, Jesus
Jin, Lixia
Schindler, Ulrike
Walters, Matthew J.
Young, Stephen W.
Walker, Nigel P.
Leleti, Manmohan Reddy
Powers, Jay P.
Jeffrey, Jenna L.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11235 - 11257
[3] Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ
Sha, Shao
Han, Hong-Wei
Gao, Fei
Liu, Tian-Bao
Li, Zhen
Xu, Chi
Zhong, Wei-Qing
Zhu, Hai-Liang
MEDCHEMCOMM, 2015, 6 (11) : 2029 - 2035
[4] Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors
Ma, Chen-Chen
Zhang, Cheng-Mei
Tang, Long-Qian
Liu, Zhao-Peng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 9 - 17
[5] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
Jia, Hong
Dai, Guangxiu
Su, Weiguo
Xiao, Kun
Weng, Jianyang
Zhang, Zhulin
Wang, Qing
Yuan, Tianhai
Shi, Fuying
Zhang, Zheng
Chen, Wei
Sai, Yang
Wang, Jian
Li, Xiong
Cai, Yu
Yu, Jun
Ren, Ping
Venable, Jennifer
Rao, Tadimeti
Edwards, James P.
Bembenek, Scott D.
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948
[6] Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
Zhou, Hua
McGowan, Meredeth A.
Lipford, Kathryn
Christopher, Matthew
Fradera, Xavier
Witter, David
Lesburg, Charles A.
Li, Chaomin
Methot, Joey L.
Lampe, John
Achab, Abdelghani
Shaffer, Lynsey
Goldenblatt, Peter
Shah, Sanjiv
Bass, Alan
Schroeder, Gottfried
Chen, Dapeng
Zeng, Haoyu
Augustin, Martin A.
Katz, Jason D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (01)
[7] Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors
Han, Fangbin
Lin, Songwen
Liu, Peng
Liu, Xiujie
Tao, Jing
Deng, Xiaobing
Yi, Chongqin
Xu, Heng
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (04): : 434 - 438
[8] PI3K delta: Discovery of potent and selective inhibitors for treating hematopoietic malignancies
Mattheakis, L.
Kearney, P.
Jaeger, C.
Plonowski, A.
Zhang, J.
Yu, P.
EJC SUPPLEMENTS, 2010, 8 (07): : 72 - 72
[9] Discovery of potent and selective PI3Kδ inhibitors bearing amino acid fragments
Lei, Hao
Duan, Weiming
Zhang, San-Qi
Feng, Yifan
Ma, Mengyan
Yuan, Bo
Xin, Minhang
BIOORGANIC CHEMISTRY, 2023, 138
[10] Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitors
Terstiege, Ina
Perry, Matthew
Petersen, Jens
Tyrchan, Christian
Svensson, Tor
Lindmark, Helena
Oster, Linda
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (03) : 679 - 687

← 1 2 3 4 5 →